Tag archive for ‘AstraZeneca plc’

Perrigo buys Crohn’s disease drug for $380 million

  Perrigo will acquire Entocort (budesonide) capsules as well as the authorized generic capsules marketed by Par Pharmaceuticals within the US from AstraZeneca plc for $380 million. Entocort, a gastroenterology More...

Wordpress site Developed by Fixing WordPress Problems